AnalystsChris RaymondChris Raymond's Stock Forecasts
AnalystsChris Raymond
Sectors:
Industries:
Analyst Ranking
Top 32%
#1652 out of 5290 analysts
Average Return
+35.18%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Chris Raymond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cogent Biosciences IncCOGT | +150.69% | $13.08 | $32.79 | 2025-09-02 - 2026-06-04 | Strong Buy |
Tyra Biosciences IncTYRA | +120.62% | $12.32 | $27.18 | 2025-09-02 - 2026-06-04 | Strong Buy |
Monopar TherapeuticsMNPR | +64.62% | $36.21 | $59.61 | 2025-09-02 - 2026-06-04 | Strong Buy |
Sionna Therapeutics IncSION | +53.89% | $24.55 | $37.78 | 2025-09-02 - 2026-06-04 | Strong Buy |
Nuvalent IncNUVL | +18.20% | $79.54 | $94.02 | 2025-09-02 - 2026-06-04 | Buy |
Chris Raymond Analyst Color
Get additional color on Chris Raymond's coverage of popular stocks
Chris Raymond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 3 | Buy | $123.00 | +106.34% | Downgrades | 7 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $45.00 | +19.11% | Initiates Coverage On | 9 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $35.00 | +28.77% | Initiates Coverage On | 9 months ago |
Nuvalent IncNUVL | 1 | Buy | $105.00 | +11.68% | Initiates Coverage On | 9 months ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $23.00 | +393.56% | Initiates Coverage On | 9 months ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $30.00 | -8.51% | Initiates Coverage On | 9 months ago |
Biohaven LtdBHVN | 1 | Strong Buy | $75.00 | +557.89% | Initiates Coverage On | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.